Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-24

Clinical Trial Update: Silodosin in Management of Lower Ureteral Stones [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating silodosin for management of lower ureteral stones across Phase 1 and Phase 2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

Sponsor: Syrian Private University | Conditions: Stone, Kidney | Phase 1, Phase 2 | Status: COMPLETED